Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.

Shiwei WangYu WangLi ZhuLiang HeMutian LvHao ZhangHaoyu WangFan ZhangYaxin LaiYushu LiZhongyan ShanWeiping Teng

Published in: Endocrine (2022)

Our study indicated that postoperative 1-year TSH suppressive therapy did not show detrimental effects on BMD and BTMs in men, premenopausal, and postmenopausal DTC patients. The 2-year postoperative TSH suppressive therapy did not lead to additional loss of bone mass in postmenopausal DTC patients.

Keyphrases

bone mineral density
postmenopausal women
end stage renal disease
body composition
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
patients undergoing
soft tissue